TITLE

Pathophysiology of Non Alcoholic Fatty Liver Disease

AUTHOR(S)
Petta, Salvatore; Gastaldelli, Amalia; Rebelos, Eleni; Bugianesi, Elisabetta; Messa, Piergiorgio; Miele, Luca; Svegliati-Baroni, Gianluca; Valenti, Luca; Bonino, Ferruccio
PUB. DATE
December 2016
SOURCE
International Journal of Molecular Sciences;Dec2016, Vol. 17 Issue 12, p2082
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style and inflammation, which have a major impact on the severity of the clinicopathologic outcome of non-alcoholic fatty liver disease. A short comprehensive review is provided on current knowledge of the pathophysiological interplay among major circulating effectors/mediators of fatty liver, such as circulating lipids, mediators released by adipose, muscle and liver tissues and pancreatic and gut hormones in relation to diet, exercise and inflammation.
ACCESSION #
120516906

 

Related Articles

  • Immunological Mechanisms in the Pathophysiology of Non-Alcoholic Steatohepatitis. Vonghia, Luisa; Michielsen, Peter; Francque, Sven // International Journal of Molecular Sciences;Oct2013, Vol. 14 Issue 10, p19867 

    Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and hepatocyte injury and constitutes hepatic manifestation of the metabolic syndrome. The pathogenesis of NASH is complex and implicates cross-talk between different metabolically active sites, such...

  • CD44 Plays a Critical Role in Regulating Diet-Induced Adipose Inflammation, Hepatic Steatosis, and Insulin Resistance. Kang, Hong Soon; Liao, Grace; DeGraff, Laura M.; Gerrish, Kevin; Bortner, Carl D.; Garantziotis, Stavros; Jetten, Anton M. // PLoS ONE;Mar2013, Vol. 8 Issue 3, p1 

    CD44 is a multifunctional membrane receptor implicated in the regulation of several biological processes, including inflammation. CD44 expression is elevated in liver and white adipose tissue (WAT) during obesity suggesting a possible regulatory role for CD44 in metabolic syndrome. To study this...

  • Non-alcoholic fatty liver disease and the metabolic syndrome: An update. Rector, R. Scott; Thyfault, John P.; Yongzhong Wei; Ibdah, Jamal A. // World Journal of Gastroenterology;1/14/2008, Vol. 14 Issue 2, p185 

    Sedentary lifestyle and poor dietary choices are leading to a weight gain epidemic in westernized countries, subsequently increasing the risk for developing the metabolic syndrome and nonalcoholic fatty liver disease (NAFLD). NAFLD is estimated to affect approximate 30% of the general US...

  • Non-Alcoholic Steatohepatitis and Hepatocellular Carcinoma: Implications for Lycopene Intervention. Ip, Blanche C.; Xiang-Dong Wang // Nutrients;Jan2014, Vol. 6 Issue 1, p124 

    Increased prevalence of non-alcoholic fatty liver disease (NAFLD) is one of the consequences of the current obesity epidemic. NAFLD is a major form of chronic liver disease that is highly prevalent in obese and overweight adults and children. Nonalcoholic steatohepatitis (NASH) is the severe...

  • Visceral Abdominal and Subfascial Femoral Adipose Tissue Have Opposite Associations with Liver Fat in Overweight and Obese Premenopausal CaucasianWomen. Rocha, Paulo M.; Barata, José T.; Minderico, Cláudia S.; Silva, Analiza M.; Teixeira, Pedro J.; Sardinha, Lúis B. // Journal of Lipids;2011, p1 

    Abdominal obesity has been associated with liver fat storage. However, the relationships between other body composition depots and metabolic syndrome features with hepatic fat are still unclear. We examined abdominal and thigh adipose tissue (AT) compartments associations with liver fat in 140...

  • Low Testosterone Promotes Abdominal Obesity in Aging Men. GOEPP, JULIUS // Life Extension;Oct2010, Vol. 16 Issue 10, p50 

    The article presents an overview of research which has found an association between testosterone insufficiency and abdominal obesity and metabolic syndrome in aging men. A discussion of the role that testosterone therapy can play in weight loss, glucose control and the prevention of a variety of...

  • Pro-inflammatory Phospholipid Arachidonic Acid/Eicosapentaenoic Acid Ratio of Dysmetabolic Severely Obese Women. Caspar-Bauguil, S.; Fioroni, A.; Galinier, A.; Allenbach, S.; Pujol, M.; Salvayre, R.; Cartier, A.; Lemieux, I.; Richard, D.; Biron, S.; Marceau, P.; Casteilla, L.; Pénicaud, L.; Mauriège, P. // Obesity Surgery;Jun2012, Vol. 22 Issue 6, p935 

    Background: Fatty acids (FAs) and adipokines such as adiponectin or interleukin-6 (IL-6) are known to modulate inflammation and the development of metabolic syndrome. Whether FA composition assessed in plasma triacylglycerols (TAGs), phospholipids (PLs) and non-esterified fatty acids (NEFAs) and...

  • Beta-Mecaptoethanol Suppresses Inflammation and Induces Adipogenic Differentiation in 3T3-F442A Murine Preadipocytes. Wen Guo; Yahui Li; Wentao Liang; Siu Wong; Apovian, Caroline; Kirkland, James L.; Corkey, Barbara E. // PLoS ONE;Jul2012, Vol. 7 Issue 7, p1 

    Preadipocytes are present in adipose tissues throughout adult life that can proliferate and differentiate into mature adipocytes in response to environmental cues. Abnormal increase in adipocyte number or size leads to fat tissue expansion. However, it is now recognized that adipocyte...

  • Perinatal Overnutrition Exacerbates Adipose Tissue Inflammation Caused by High-Fat Feeding in C57BL/6J Mice. Kayser, Brandon D.; Goran, Michael I.; Bouret, Sebastien G. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Obesity causes white adipose tissue (WAT) inflammation and insulin resistance in some, but not all individuals. Here, we used a mouse model of early postnatal overfeeding to determine the role of neonatal nutrition in lifelong WAT inflammation and metabolic dysfunction. C57BL/6J mice were reared...

  • The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review. Kucerova, Jana; Babinska, Zuzana; Horska, Katerina; Kotolova, Hana // Biomedical Papers of the Medical Faculty of Palacky University i;Jun2015, Vol. 159 Issue 2, p208 

    Background. There is a growing interest in metabolic alterations in patients with psychiatric disorders due to their increased risk for metabolic syndrome (MetS) development. Inflammation is known to underlie the pathophysiology of schizophrenia and depression as well as MetS. Vulnerability...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics